Vir Biotechnology has partnered with Astellas Pharma to develop VIR-5500, its masked PSMA-targeting T-cell engager for ...

Dozens of investigations, audits, recounts and court proceedings examined the 2020 election. None found the widespread voter ...

The agency has used the controversial surveillance devices for more than a decade, according to credible investigative ...

Introduction Patients with SLE have an increased risk of infections and infection-related mortality, which may be associated ...

CBAK Energy Technology Limited (NASDAQ: CBAT) (“CBAK Energy” or the “Company”), a leading lithium-ion battery manufacturer ...

Certain gut bacteria may influence the odds of developing MS, in part by altering the activity of specific immune cells, ...

A paper published in the journal Biomarker Research by a cross-university team led by Queen Mary University of London ...

Bloom Energy and global investment firm Brookfield expanded their strategic partnership fivefold on June 30, 2026 — from $5 billion to $25 billion — in a deal that signals something larger than a ...

In this important study, the authors present an interesting platform for digital twin construction of iPSC-CMs using an AI-based approach. The concept is timely and could have meaningful impact as the ...

SHANGHAI, NANJING, and PLEASANTON, Calif., June 18, 2026 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceutical company focused on the discovery, development, ...

CHARLOTTE, N.C. — Autologous hematopoietic stem cell transplant (aHSCT), pursued for decades as a potential cure for multiple sclerosis (MS), is associated in the modern era with a high potential for ...

The efficacy of teclistamab, a bispecific antibody targeting B-cell maturation antigen and CD3, as early-line monotherapy in relapsed or refractory multiple myeloma is unclear. We randomly assigned ...